AGP Executive Report
Last update: 9 hours agoNewborn Vaccine Study: Guinea-Bissau’s health minister says the government has not approved a proposed U.S.-funded hepatitis B study in newborns, contradicting reports that it had the green light. The Danish university overseeing the research approved a revised plan involving 14,000 babies, with half scheduled to receive the vaccine at six weeks rather than at birth; babies born to mothers who test positive for hepatitis B would be excluded. The study cannot begin without Guinea-Bissau’s authorization. Health Minister Quinhin Nantote said research involving children must meet national law and international ethical standards. The hepatitis B birth dose helps prevent infection passed from mother to child.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
